FindTrial
Sign In

Diagnostic value of C1q in sarcopenia

Diagnostic value of C1q in sarcopenia in patients with liver cirrhosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000028837
Enrollment
Unknown
Registered
2020-01-05
Start date
2020-01-01
Completion date
Unknown
Last updated
2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sarcopenia

Interventions

Gold Standard:Clinical outcome
Index test:Complement C1q

Sponsors

Shanxi Academy of Medical Sciences Shanxi Bethune Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Patient group: 1. Unlimited for men and women; 2. Sign informed consent. According to the clinical diagnosis of sarcopenia patients to collect the corresponding samples of patients. control group: 1. Unlimited for men and women; 2. People with good physical examination results; 3. Sign informed consent.

Exclusion criteria

Exclusion criteria: 1. It is necessary for researchers to suspend the trial from the perspective of medicine; 2. The patient requests to stop to participate the study.

Design outcomes

Primary

MeasureTime frame
Complement C1q;SEN, SPE, ACC, AUC of ROC;—

Countries

China

Contacts

Public ContactZhang Mingxia

Shanxi Academy of Medical Sciences, Shanxi Dayi Hospital

sxdyy8358@126.com+86 0351 8368562

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026